| Name | Title | Contact Details |
|---|
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
American Healthguard Dental Plan is a Arcadia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AirLife is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New Jersey Organ and Tissue is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New Jersey Organ and Tissue is based in New Providence, NJ. You can find more information on New Jersey Organ and Tissue at www.sharenj.org
Kensey Nash Corporation is a medical device company known for product development and technology in the fields of resorbable biomaterials used in a variety of medical procedures and endovascular devices. The Company provides a range of products into